MARISSA EVANCHO: Open Payments
NPI 1427647817 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 47 payments from 14 companies in 2025. Trend: 2023 $592 · 2024 $775 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $182 |
| PFIZER INC. | 9 | $157 |
| Novo Nordisk Inc | 6 | $105 |
| Amgen Inc. | 5 | $80 |
| Esperion Therapeutics, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| ABIOMED | 1 | $40 |
| Kestra Medical Technology Services, Inc. | 1 | $25 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: LEQVIO, VYNDAQEL, REPATHA, Wegovy, NEXLETOL, WAINUA, Ozempic, Assure WCD.
Industry payments across OH — which companies pay providers there.
